Psychopharmacology

, Volume 103, Issue 1, pp 1–5 | Cite as

Study of the P300 and cerebral maps in subjects with multi-infarct dementia treated with cytidine

  • V. Gallai
  • G. Mazzotta
  • C. Firenze
  • S. Montesi
  • F. Del Gatto
Original Investigations

Abstract

A study of event-related P300 potential and cerebral EEG maps was performed in 20 patients affected by multi-infarct dementia (MID): 10 subjects were treated with placebo and 10 with cytidine. The trial was divided into three intervals. The patients, after a period of washout, were evaluated throughout the course of the trial by electrophysiological examination performed at baseline, after 90 min from the first IV injection, again after 30 days of IM therapy, and finally after 60 days of continued IM therapy. In the group treated with cytidine, the findings relevant to the study of the P300 showed a significant decrease in latency values compared to baseline (P<0.05 ANOVA) and an improvement, though not significant, in the amplitude values. Calculation of the mean relative power of EEG values showed a significant decrease in delta activity and an increase in alpha activity. In the subjects treated with placebo, no statistically significant variation was found in either P300 or EEG map recordings. On the basis of these investigations it has been demonstrated that the variations in the registrations can be correlated to the improved neuronal activity following treatment with cytidine.

Key words

Cytidine Multi-infarct dementia P300 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agnoli A, Manna V, Bocoli V, Matucci N (1981) Chronic cerebrovascular disorders: modification of the EEG spectral analysis determined by dehydroergocristine methasulphonate. Curr Ther Res 9:321–326Google Scholar
  2. Agnoli A, Martucci N, Manna V, Conti L, Fioravanti M (1983) Effect of cholinergic and anticholinergic drugs of short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study. Clin Neuropharmacol 6:311–323Google Scholar
  3. Benzi A, Arrigoni E, Marzatico F, Villa R (1979) Influence of some biological pyrimidines on the succinate cycle during and after cerebral ischemia. Biol Pharmacol 28:2545–2550Google Scholar
  4. Cosmi F, Caresia L, Panebianco G (1986) Nimodipina e diidroergotossina. Clin Ter 116:213–220Google Scholar
  5. Donchin E (1977) Surprise?... Surprise!... Psychophysiology 25:145–152Google Scholar
  6. Duffy F, Burchfiel J, Lombroso C (1979) Brain electrical activity mapping (BEAM): a method for extending the clinical utility of EEG and evoked potential data. Ann Neurol 5:309–321Google Scholar
  7. Duffy F, Albert M, McAnulty G, Garvey A (1984) Age relation differences in brain electrical activity of healthy subjects. Ann Neurol 16:439–448Google Scholar
  8. Duncan-Johnson C (1981) P300 latency: a new metric of information processing. Psychophysiology 18:207–215Google Scholar
  9. Firenze C, Mazzotta G, Mattelli L, Bruni A, Montesi S, Gallai V (1988) Studio della P300 mediante mappe cerebrali in soggetti con vascolopatia cerebrale cronica dopo terapia con l'associazione citidina, uridina, N-acetil-glutamina. In: Atti del IX corso di aggiornamento della Società Italiana di Neurologia. Assisi, pp 210–213Google Scholar
  10. Firenze C, Mazzotta G, Montesi S, Gallai V (1989) Studio della P300 e delle mappe cerebrali in soggetti con demenza multiifartuale (MID) trattati con l'associazione citidina, uridina,l-glutamina. Basi Raz Ter 19:683–688Google Scholar
  11. Fischer C (1978) Dementia in cerebrovascular disease. In: Trans VI Congress Cerebrovascular Disease. Grune and Stratton, New York, pp 89–102Google Scholar
  12. Floridi A, Vecchini A, Palmerini CA, Binaglia L, Porcellati G (1981) Cytidine diphosphate choline (CDP-choline) uptake by cultured brain cells. Ital J Biochem 30:317–324Google Scholar
  13. Folstein M, Folstein S, McHugh P (1977) “Mini mental state”: a practical method for grading the cognitive state of patients for the clinic. J Psychiatr Res 12:189–198Google Scholar
  14. Geiger A, Yamasaki S (1956) Cytidine and uridine requirement of the brain. J Neurochem 1:93–96Google Scholar
  15. Gershon S, Herman S (1982) The differential diagnosis of dementia. J Am Geriatr Soc 30:2–58Google Scholar
  16. Goodin D, Squires K, Starr A (1978) Long latency event-related components of, the auditory evoked potential in dementia. Brain 101:635–648Google Scholar
  17. Hachinski V, Lassen NA, Marshall J (1974) Multiinfarct dementia: a cause of mental deterioration in the elderly. Lancet II:207–213Google Scholar
  18. Harrison M, Marsden C (1977) Progressive intellectual deterioration. Arch Neurol 34:199–205Google Scholar
  19. Hughes C, Berg I, Danziger W, Cohen I, Marin R (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:556–572Google Scholar
  20. Hylliard S, Kutas M (1983) Electrophysiology of cognitive processing. Annu Rev Psychology 34:33–61Google Scholar
  21. Katz R, Horowitz G (1982) The septuagenarian EEG: studies in a selected normal geriatric population. J Am Geriatr Soc 3:273–276Google Scholar
  22. Loeb C, Gandolfo C (1983) Diagnostic evaluation of degenerative and vascular dementia. Stroke 14:399–405Google Scholar
  23. Mahendra B (1983) Dementia: a survey of the syndrome of dementia. MTP Press Limited, pp 167–183Google Scholar
  24. Manna V, Martucci N (1990) Effects of short term administration of cytidine, uridine andl-glutamine, alone or in combination, on the cerebral electrical activity of patients with chronic cerebrovascular disease. Acta Neurol (in press)Google Scholar
  25. Martucci N, Caratazzolo P, Ciabatti P, Proietti R, Manna V (1986) Le cerebopatie vascolari croniche: Valutazione clinica neuropsicologica dell'effetto del trattamento con citidina, uridina,l-glutamina in associazione. Giornale Ital Neuropsicofarm 8:267–274Google Scholar
  26. Matejcek M, Knor K, Piquet P, Weil C (1979) Correlazioni fra variazioni elettroencefalografiche e cliniche in pazienti geriatrici trattati per tre mesi con hydergina. J Am Geriatr Soc 27:198–205Google Scholar
  27. Nagata K, Tagawa K, Shisido F, Uemura K (1986) Topographic EEG correlates of cerebral blood flow and oxygen consumption in patients with neuropsychological disorders. In: Duffy F (ed) Topographic mapping of brain electrical activity. Butterworths, Boston, pp 357–370Google Scholar
  28. O'Connor K (1977) Contingent negative variation: CNV differences between elderly normal and demented subjects. EEG Clin Neurophysiol 51:666–670Google Scholar
  29. Pedley T, Miller J (1983) Clinical neurophysiology of aging and dementia. In: Mayeux R (ed) The dementias. Raven Press, New York, pp 78–93Google Scholar
  30. Robins RK (1975) Nucleotides and nucleosides: past, present and future. Ann New York Acad Sci 255:597–601Google Scholar
  31. Roth M (1981) The diagnosis of dementia in late and middle life. In: Mortimer J, Schuman L (eds) The epidemiology of dementia. Oxford University Press, New York, pp 45–51Google Scholar
  32. Roubicek J (1977) The EEG in the middle-aged and the elderly. J Am Geriatr Soc 25:145–152Google Scholar
  33. Spinnler H (1985) Il decadimento demenziale. Inquadramento neurologico e neuropsicologico. Il Pensiero Scientifico (ed), RomaGoogle Scholar
  34. Trovarelli G, Palmerini CA, Floridi A, Piccinin GL, Porcellati G (1984) The influence of cytidine on the endogenous pool of CDP-choline, CDP-ethanolamine and CMP of the rat brain. J Neurochem Res 9:73–79Google Scholar
  35. Villardita C, Smirni P, Bozzanca L, Nicoletti F, Drago F (1983) Effects of pyrimidine nucleosides and N-acetyl-glutamine on learning and memory in men of various ages. Acta Ther 9:407–416Google Scholar
  36. Wisniewski H, Terry RD (1976) Neuropathology of the aging brain. In: Terry RD, Gershon S (eds) Aging. Raven Press, New YorkGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • V. Gallai
    • 1
  • G. Mazzotta
    • 1
  • C. Firenze
    • 1
  • S. Montesi
    • 1
  • F. Del Gatto
    • 1
  1. 1.Istituto di Clinica delle Malattie Nervose e Mentali, Cattedra di Terapia NeurologicaUniversità di PerugiaPerugia, Succ. 3Italy

Personalised recommendations